Essilor Overview

  • Founded
  • 1848
Founded
  • Status
  • Public
  • Employees
  • 144,512
Employees
  • Stock Symbol
  • EL
Stock Symbol
  • Investments
  • 201
  • Share Price
  • $198.53
  • (As of Monday Closing)

Essilor General Information

Description

EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command around 15% of the fragmented global eyewear market. The combined company has a broad geographical presence, with around 24% of sales in Europe, 53% in the North America, and the rest in Asia and Latin America.

Contact Information

Website
www.essilor.com
Formerly Known As
Compagnie Generale D'Optique
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Stock Exchange
PAR
Primary Office
  • 147 rue de Paris
  • 94220 Charenton-le-Pont
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Essilor Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$198.53 $195.46 $140.88 - $221.67 $87.6B 441M 519K $3.67

Essilor Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 85,953,068 74,193,119 72,278,079 56,503,672
Revenue 20,225,777 16,447,803 19,467,144 12,786,019
EBITDA 4,931,575 2,927,296 4,223,665 3,077,613
Net Income 1,610,481 96,893 1,205,642 1,278,012
Total Assets 63,991,860 64,349,409 58,902,007 55,362,617
Total Debt 13,581,892 14,630,456 10,546,420 6,521,391
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Essilor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Essilor‘s full profile, request access.

Request a free trial

Essilor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufactu
Therapeutic Devices
Charenton-le-Pont, France
144,512 As of 2020
000000000

000000 +

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
00000000000 0000000
Bridgewater, NJ
00000 As of 0000
000
00000000

00000000

ugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia dese
00000000000 0000000
Irvine, CA
00 As of 0000
0000
0000 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Essilor Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bausch + Lomb Formerly PE-Backed Bridgewater, NJ 00000 000 00000000
00000000 Venture Capital-Backed Irvine, CA 00 0000 00000000000 0000
0000 00000 Corporation Tokyo, Japan 00000
0000 00000 0000000 Corporation Jena, Germany 0000 00000 00000000 00000
To view Essilor’s complete competitors history, request access »

Essilor Patents

Essilor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-202021002353-U1 Glasses Active 10-Jul-2020 00000000
US-6911485-B1 Adding to precursor monomers or oligomers or polymers or copolymers an effective amount of at least one complex of cobalt, molybdenum or tungsten under irradiation conditions to initiate polymerization or crosslinking Expired - Fee Related 19-Apr-2002 00000000 0
EP-1497337-B1 Anionic and lewis base photopolymerization process and its use for making optical articles Expired - Fee Related 19-Apr-2002 00000000
US-7253213-B2 Adding to precursor monomers or oligomers or polymers or copolymers an effective amount of at least one complex of cobalt, molybdenum or tungsten under irradiation conditions to initiate polymerization or crosslinking Expired - Fee Related 19-Apr-2002 00000000 0
DE-60334290-D1 Anionic and lewis base photopolymerization processes and their use in optical objects Active 19-Apr-2002 C08F2/50
To view Essilor’s complete patent history, request access »

Essilor Executive Team (36)

Name Title Board Seat Contact Info
Francesco Milleri Chief Executive Officer
Paul Du Saillant Deputy CEO
David Wielemans Chief Financial Officer
Eric Thoreux Co-Chief Operating Officer & Board Member
Norbert Gorny Co-Chief Operating Officer & Board Member
You’re viewing 5 of 36 executive team members. Get the full list »

Essilor Board Members (7)

Name Representing Role Since
0000000 00000 Self Board Member 000 0000
0000 0000000 Essilor Co-Chief Operating Officer & Board Member 000 0000
0000000 00000 Essilor Co-Chief Operating Officer & Board Member 000 0000
0000000 0é0000 Self Board Member, EssilorLuxottica 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Essilor Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Essilor Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Essilor‘s full profile, request access.

Request a free trial

Essilor Investments & Acquisitions (201)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 ( 01-Jul-2021 0000000000 00.000 Specialty Retail 000000000
0000000 00000 27-Apr-2021 0000000000 Therapeutic Devices 0000000 0
000000 000000 25-Mar-2021 0000000000 Therapeutic Devices 0000 00 0
0000000000 00 03-Feb-2021 0000000000 Therapeutic Devices
NovaSight 13-Jul-2020 Early Stage VC 000 Therapeutic Devices
You’re viewing 5 of 201 investments and acquisitions. Get the full list »

Essilor Subsidiaries (103)

Company Name Industry Location Founded
SightGlass Vision Therapeutic Devices Palo Alto, CA 2016
00000000 0000000 0 Accessories Oaxaca, Mexico 0000
0Ó0000 Specialty Retail Sao Paulo, Brazil 0000
0-0000 (000000) Personal Products Sao Paulo, Brazil 0000
000000000000 00000 Other Healthcare Services West Covina, CA 0000
You’re viewing 5 of 103 subsidiaries. Get the full list »

Essilor Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 12-May-2009 00000 00000 00 00.000 Completed
  • 6 buyers
0000 23-Sep-2008 00000 00000 00 000 Completed
  • 6 buyers
0000 25-Jun-2007 00000 00000 00 00.000 Completed
  • 6 buyers
Polylite Taiwan Company 01-Jan-2006 Merger/Acquisition Completed
To view Essilor’s complete exits history, request access »